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Reductionism ^ the search for the ultimate building blocks of life
^ comes with an obligation: to eventually put the pieces back to-
gether.This is harder than it looks, because it involves ¢nding the
relationships between the pieces. These usually went through the
tissue grinder on the way down. Albert Szent-Gy˛rgyi once re-
£ected, ‘‘In my hunt for the secret of life, I started my research in
histology. Unsatis¢ed, I turned to physiology y pharmacology
y bacteriology. But bacteria were even too complex, so I des-
cended to the molecular level. But electrons are just electrons,
and have no life at all. Evidently on the way I had lost life; it
had run out between my ¢ngers’’ (Wilson et al, 1973).
In the case of skin cancer, attention has focused on mutated
genes. The multiple genetic hit model for cancer has been a spec-
tacular success, yielding ‘‘gatekeeper’’genes likeAPC in colon can-
cer and PTCH in basal cell carcinoma of the skin. Gatekeepers
single out a particular tissue for cancer development by acting as
a tissue speci¢c rate-limiting step. Genetics has also identi¢ed
‘‘caretaker’’genes that prevent mutations in gatekeepers, including
MLH1 and MSH2 mismatch repair genes in hereditary colon
cancer, the BRCA putative repair genes in hereditary breast can-
cer, and the XP and CS repair gene families that underlie the sun-
sensitive and cancer-prone disorders xeroderma pigmentosum
and Cockayne syndrome. In contrast to these caretaker genes,
P53 ^ which is involved in DNA repair and in apoptosis of dam-
aged cells ^ is mutated not only in rare hereditary cancers but also
in the majority of sporadic tumors, including basal and squamous
cell carcinomas of the skin (Brash and Bale, 2001).
But mutated genes are embedded in a larger process (Fig 1). It
is now feasible to begin reassembling these pieces. The initial
steps, such as mutation by sunlight, are well-understood for skin
cancer though poorly understood for other cancers. An essential
point is that mutation frequencies are known, and range from
10^8 per gene per cell generation for spontaneous polymerase er-
rors to 10^3 for moderate doses of UVB radiation (McGregor et al,
1991). Even genomic instability occurs at 10^3 or less (Wang et al,
2002), and usually only in about 15% of sporadic cancers. So if 6
genes must be mutated for a tumor to arise (a ¢gure at the con-
servative end of estimates from human age-incidence data (Stein,
1991)), and some are tumor suppressor genes that must be mu-
tated in both alleles, then approximately 10 hits are required. The
likelihood of a single cell sustaining all the required mutations is
approximately 10^30. Since the number of proliferating keratino-
cytes in human skin is only about 106 per cm2 (Bergstresser et al,
1978), with about 1000 cm2 of skin exposed, this is not going to
happen. For this reason, the multiple genetic hit model of cancer
is critically dependent on a physiological trick: after the ¢rst mu-
tation is made, the mutant cell clonally expands. The target size
increases by 100^1000 fold, and only one of these cells needs to be
hit the second time. If the mutation frequency is 10^3 and clonal
expansion is 103-fold, the subsequent mutation is a certainty.
(Gene ampli¢cation could conceivably achieve the same end.)
Thousands of clones of P53-mutant keratinocytes indeed reside
in sun-exposed human epidermis and UVB-irradiated mouse
skin (Brash and Bale, 2001; Zhang et al, 2001). But what drives
clonal expansion? Is it sunlight, and, if so, how?
Into this breach step Mudgil et al (p. 191). The group has con-
structed organotypic cultures in which normal human keratino-
cytes (NHK) are grown on a collagen matrix overlaid with
dermal ¢broblasts. The NHK are allowed to di¡erentiate, so that
cells in the basal layer proliferate and di¡erentiate upward to
make a keratinized layer at the air^liquid interface. The NHK
are then mixed with II-4 cells, a cell line of early stage malignant
human keratinocytes carrying mutations in each P53 allele and
carrying an activated HRAS oncogene; the cells are also geneti-
cally marked with the bacterial b-galactosidase gene to enable
easy visualization. In previous work, the group showed that a
normal:premalignant ratio of 4:1 led to elimination of the prema-
lignant cells by inducing their cell cycle withdrawal and terminal
di¡erentiation (Javaherian et al, 1998). At a 1:1 ratio, the premalig-
nant cells survived, proliferated, and invaded. The tumor promo-
ter TPA facilitated clonal expansion of the premalignant cells, by
inhibiting NHK proliferation and inducing their di¡erentiation
(Karen et al, 1999).
The e¡ect of ultraviolet B radiation (UVB) on a mixture of
normal and premalignant cells was striking. Using doses corre-
sponding to a minimal erythemal dose (MED) or less, the
authors ¢rst found that UVB allows the premalignant cells to
form clones even at normal:premalignant cell ratios that would
otherwise have led to their disappearance.The mutants eventually
occupied 28% of the tissue area. Double labeling with bromo-
deoxyuridine revealed that during this occupation only the pre-
malignant cells were proliferating. Was UVB aiding the
premalignant cells or restraining the normal NHK? Pure NHK
cultures showed a dose-dependent increase in apoptotic sunburn
cells and soundbreak-positive cells, while their proliferation was
suppressed 10-fold. In contrast, pure II-4 cells showed neither
UVB-induced apoptosis nor suppression of proliferation.The de-
fective apoptosis was expected from the P53 mutations (Brash
and Bale, 2001), but the e¡ect was even greater in the presence
of activated RAS, which suppresses apoptosis in many systems.
Activated RAS also interferes with the G1/S cell cycle checkpoint
that restrains proliferation. The opposite reactions of normal and
premalignant keratinocytes to UVB would lead to apoptosis of
normal keratinocytes, after which the premalignant cells would
preferentially repopulate the ‘‘microscopic burn wound’’, as pro-
posed a number of years ago (Brash and Bale, 2001). End result:
each trip to the beach becomes a selection pressure favoring mu-
tant cells. Although UVB-induced apoptosis appears to be a
powerful protective mechanism preventing sunlight-mutated
cells from accumulating in the epidermis, the system back¢res
when a P53 mutation is present.
These molecular results complement recent visual observations
on UVB-induced clonal expansion in mouse skin in vivo (Zhang
et al, 2001). Chronic irradiation leads to more and larger P53-mu-
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tant clones. A geneticist might expect the e¡ect on clone size
to come from a UV-induced mutation in a second gene, one
controlling cell proliferation. Alternatively, expansion might be
due to a physiological e¡ect of UVB. In the genetic mechanism,
a clone would continue to irreversibly expand once mutated,
whether or not UVB exposure continued; in the physiological
version, each increment of clonal expansion would depend on
additional exposure. The latter was the case: clonal expansion
stopped when UVB ceased. UVB-induced apoptosis and di¡er-
ential proliferation would ful¢l this physiological role. A second
visual ¢nding was that clone size was quantized, occuring in
multiples of one murine stem cell compartment. UVB’s role was
to allow escape into an adjacent stem cell compartment. UVB-
induced apoptosis would accomplish this by providing a steady
source of vacated compartments.
Clonal expansion is evidently so important that it is normally
suppressed. In the organotypic system, neighboring NHK in-
duced premalignant keratinocytes to di¡erentiate. Other work
has found tumor-suppressive e¡ects from dermal ¢broblasts
(Dotto et al, 1988), prostate ¢broblasts, and tracheal epithelium
(reviewed in Rubin, 2002). An important step in tumor develop-
ment is the escape from this suppression. Preneoplastic tracheal
epithelial cells no longer inhibited the proliferation of neoplastic
epithelial cells, and ¢broblasts derived from human prostate car-
cinoma allowed immortalized prostate epithelial cells to progress
to a tumor. These phenomena may re£ect mutations or physiolo-
gical changes in the cells surrounding the tumor’s cell of origin,
something of a terra incognita in cancer biology. In the organo-
typic system, as in vivo (Rubin, 2002) tumor promoters such as
TPA and UVB handicap the normal keratinocytes by inducing
their di¡erentiation or apoptosis, and inhibiting their prolifera-
tion, while allowing malignant cells to proliferate. Chemical car-
cinogens can facilitate clonal expansion of pre-existing
spontaneously mutant cells, recognized as such because their mu-
tation signature does not match that of the carcinogen itself (Cha
et al, 1994; Rubin, 2002). Since many gatekeeper tumor suppressor
genes have roles in embryonic development, losing them may
achieve escape by genetic means. Given the drama of suppression
and escape, it is well to remember that everything in life is a se-
lection pressure. The cycle of suppression and escape selects ^
even in the absence of an exogenous carcinogen or promoter ^
for cells that resist suppression. This fact is visible during serial
passages of 3T3 ¢broblasts or chicken embryo cells infected with
Rous sarcoma virus (Rubin, 2002), where the cell’s need for trans-
formation-permissive conditions diminishes with passage.
So as we work our way back up from photon to tumor, we see
that mutant genes can be tied together by the physiology of the
cells that contain them. In contrast, phosphorylate-and-bind stories
remain parked at the molecular level. Some caveats remain. As with
an earlier study showing an association between hypoxia-induced
apoptosis and clonal expansion of P53-mutant tumor cells in the
hypoxic tumor core, it remains to be shown that the observed
apoptosis is actually responsible for the observed clonal expansion.
For example, UVB’s key e¡ect might be to suppress whatever sig-
nal allows NHK to induce di¡erentiation in the premalignant cells.
These are harder experiments, but they become feasible in the ele-
gant organotypic culture system of Mudgil et al. Even now, how-
ever, it seems clear that UVB will have two roles in skin cancer:
mutation and clonal expansion; initiation and promotion.
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Figure1. The multiple genetic hit model of cancer relies on physiol-
ogy. Cancer typically begins when a carcinogen such as sunlight or body
temperature alters DNA’s chemical structure, creating an abnormal nucleo-
tide such as a cyclobutane dimer or abasic site. During DNA replication, an
incorrect guess by the polymerase leads to insertion of a normal, but incor-
rect, base at this site ^ a mutation. Imperfect polymerases and viral insertion
cause mutations without a carcinogen. Because point mutation frequencies
are only 108^103 per gene per cell generation, even after carcinogen ex-
posure or with genomic instability, the likelihood of mutating in a single
cell the 6^12 genes needed for an adult onset cancer is 1030 or less. This
paradox is relieved by clonal expansion, in which a cell carrying the ¢rst
mutation is copied to make a larger target of 100 cells or more, only 1 of
which must sustain the next mutation. Mudgil et al show that UVB induces
apoptosis and suppresses proliferation only in normal human keratinocytes,
allowing premalignant keratinocytes to clonally expand.
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